These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 16821212

  • 1. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M, Banaś M, Zahorska-Markiewicz B, Kuglin D, Mokrzycka J, Mentel A.
    Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
    [Abstract] [Full Text] [Related]

  • 2. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocełak P, Janowska J, Semik-Grabarczyk E.
    Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
    [Abstract] [Full Text] [Related]

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

  • 4. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct 07; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 5. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 07; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 6. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J, Álvarez-Mon M, Reyna-Villasmil E, Torres-Cepeda D, Santos-Bolívar J, Reyna-Villasmil N, Suarez-Torres I, Bravo-Henríquez A.
    Endocrinol Nutr; 2015 Jan 07; 62(1):31-7. PubMed ID: 25458401
    [Abstract] [Full Text] [Related]

  • 7. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb 07; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 8. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr 07; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 9. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A, Noyan V, Sagsoz N.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):81-6. PubMed ID: 16337726
    [Abstract] [Full Text] [Related]

  • 10. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul 01; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 11. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep 01; 180():56-60. PubMed ID: 25020276
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B, Radzikowska M, Wasilewska-Dziubińska E, Kapliński A, Roguski K, Płonowski A.
    Gynecol Endocrinol; 1999 Oct 01; 13(5):344-51. PubMed ID: 10599552
    [Abstract] [Full Text] [Related]

  • 13. [Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome].
    Mejia-Montilla J, Reyna-Villasmil E, Torres-Cepeda D, Santos-Bolívar J, Reyna-Villasmil N, Bravo-Henríquez A.
    Endocrinol Nutr; 2012 Jan 01; 59(1):21-7. PubMed ID: 22115703
    [Abstract] [Full Text] [Related]

  • 14. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V, Federico P, Lo Iudice G, Rispoli C, Sabatino P, D'Alessandro B.
    Minerva Endocrinol; 1992 Jan 01; 17(1):21-9. PubMed ID: 1495451
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like factor 3 -- a new hormone related to polycystic ovary syndrome?
    Szydlarska D, Grzesiuk W, Trybuch A, Kondracka A, Kowalik I, Bar-Andziak E.
    Endokrynol Pol; 2012 Jan 01; 63(5):356-61. PubMed ID: 23115068
    [Abstract] [Full Text] [Related]

  • 16. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.
    Ann Endocrinol (Paris); 2015 Oct 01; 76(5):620-7. PubMed ID: 26514948
    [Abstract] [Full Text] [Related]

  • 17. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A, Fallahzadeh H, Nadjarzadeh A.
    J Hum Nutr Diet; 2017 Jun 01; 30(3):275-283. PubMed ID: 28466507
    [Abstract] [Full Text] [Related]

  • 18. Serum HLA-G levels in women with polycystic ovary syndrome.
    Oztekin O, Fenkci SM, Fenkci V, Enli Y, Cabus U.
    Gynecol Endocrinol; 2015 Mar 01; 31(3):243-6. PubMed ID: 25403326
    [Abstract] [Full Text] [Related]

  • 19. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug 01; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 20. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun 01; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.